Follow
Laura Ruiz
Laura Ruiz
Verified email at iib.uam.es
Title
Cited by
Cited by
Year
SIRT1 controls acetaminophen hepatotoxicity by modulating inflammation and oxidative stress
P Rada, V Pardo, MA Mobasher, I García-Martínez, L Ruiz, ...
Antioxidants & redox signaling 28 (13), 1187-1208, 2018
1082018
Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
S Valle, S Alcalá, L Martin-Hijano, P Cabezas-Sáinz, D Navarro, ...
Nature Communications 11 (1), 5265, 2020
892020
A novel glucagon‐like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice
MP Valdecantos, V Pardo, L Ruiz, L Castro‐Sánchez, B Lanzón, ...
Hepatology 65 (3), 950-968, 2017
842017
ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity
S Alcalá, P Sancho, P Martinelli, D Navarro, C Pedrero, L Martín-Hijano, ...
Nature communications 11 (1), 2682, 2020
772020
Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
M Alonso-Nocelo, L Ruiz-Cañas, P Sancho, K Görgülü, S Alcalá, ...
Gut 72 (2), 345-359, 2023
262023
Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells
S Alcalá, V Mayoral-Varo, L Ruiz-Cañas, JC López-Gil, C Heeschen, ...
International journal of molecular sciences 21 (20), 7437, 2020
232020
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer
KJ Frank, A Mulero-Sanchez, A Berninger, L Ruiz-Canas, A Bosma, ...
Cell Reports Medicine 3 (11), 2022
212022
Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases
I García-Ruiz, NB Ruiz, P Rada, V Pardo, L Ruiz, A Blas-García, ...
Redox biology 26, 101263, 2019
212019
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
JF Díaz-Alejo, S April-Monn, M Cihova, V Buocikova, JV López, ...
JoVE (Journal of Visualized Experiments), e65229, 2023
22023
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy
S Alcalá, L Villarino, L Ruiz-Cañas, JR Couceiro, M Martínez-Calvo, ...
Journal of Experimental & Clinical Cancer Research 43 (1), 33, 2024
12024
Platinum iodido drugs show potential anti-tumor activity, affecting cancer cell metabolism and inducing ROS and senescence in gastrointestinal cancer cells
J Melones-Herrero, S Alcalá, L Ruiz-Cañas, C Benítez-Buelga, ...
Communications Biology 7 (1), 353, 2024
2024
Abstract C079: Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new approach to treat pancreatic cancer
BJ Sainz, S Alcalá, L Villarino, L Ruíz-Cañas, J Couceiro, ...
Cancer Research 84 (2_Supplement), C079-C079, 2024
2024
Aurora-Kinase-A-Inhibition als vielversprechende Therapiestrategie in ARID1A-mutierten Neuroendokrinen Karzinomen: Erste Ergebnisse einer in vitro und in vivo Studie
F Viol, T Amin, B Sipos, T Fründt, M Fahl, B Smolkova, B Sainz, J Earl, ...
Zeitschrift für Gastroenterologie 61 (08), KV255, 2023
2023
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment
R Carrión-Marchante, C Pinto-Díez, JI Klett-Mingo, E Palacios, ...
Pharmaceutics 15 (4), 1273, 2023
2023
PPAR-delta acts as a metabolic master checkpoint for metastasis in pancreatic cancer
B Parejo-Alonso, D Barneda, S Trabulo, S Courtois, S Compte-Sancerni, ...
bioRxiv, 2021.11. 15.468579, 2021
2021
Tailored ruthenium complexes target pancreatic cancer stem cells through inhibition of mitochondrial DNA transcription
B Sainz Jr, S Alcala, JR Couceiro, L Ruiz-Cañas, M Martínez-Calvo, ...
Pancreatology 21, S15, 2021
2021
Modulation of SIRT1 by IL1b/NFkB signaling during acetaminophen-induced hepatotoxicity
P Rada, V Pardo, MA Mobasher, I García Martínez, L Ruiz-Cañas, ...
2018
Regulacion de la homeostasis glucémica y del metabolismo lipídico por el factor de transcripción ALX3
L Ruiz Cañas
Regulacion de la homeostasis glucémica y del metabolismo lipídico por el …, 2017
2017
Differential efficacy of a GLP-1R/GCGR agonist versus a GLP-1R agonist in improving hepatic insulin sensitivity and reducing steatosis in obese mice
P Valdecantos, L Ruiz-Canas, P Rada, A Gonzalez-Rodrignez, A Konkar, ...
DIABETOLOGIA 59, S374-S374, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–19